Infusion Therapy - Conserving Supplies in the Age of COVID-19
An ECRI lab webcast
View a recording of our April 8, 2020, live-streamed lab webcast, to identify key considerations when using infusion pumps with long extension sets to conserve personal protective equipment, navigate consumables shortages or allocation situations and identify suitable alternatives, and plan ahead to mitigate infusion therapy challenges. The presentation concludes with an informative Q&A session based on questions from hospitals around the globe.
- Dr. Andrew Furman, Executive Director, Clinical Excellence, ECRI
- Erin Sparnon, Senior Engineering Manager, Device Evaluation, ECRI
- Michael Cohen, President, ISMP
- Michelle Mandrack, Director of Consulting Services, ISMP
Lab tour recording
Which infusion supplies are in short supply? Take our one-question survey.
- Large-Volume Infusion Pump Administration Sets—Responding to Possible Availability Disruptions (ECRI Exclusive User Experience Network) (4/3/20). Accession No. S0393.
- Large-Volume Infusion Pumps—Considerations When Used with Long Extension Sets outside Patient Rooms to Help Reduce Staff PPE Use (ECRI Exclusive User Experience Network) (4/2/20). Accession No. S0392.
ECRI is here to help
Our interdisciplinary staff is here to help you address your most challenging issues in your response to COVID-19. We have compiled free resources in the ECRI COVID-19 Resource Center. Please contact us for assistance and to learn more.
* All material in this COVID-19 Resource Center, https://www.ecri.org/coronavirus-covid-19-outbreak-preparedness-center/, is protected by copyright, and all rights are reserved under international and Pan-American copyright conventions. However, in light of current circumstances, due to the COVID-19 pandemic, ECRI will permit the ECRI content accessible from this COVID-19 Resource Center to be reproduced and shared, in whole or in part, for non-commercial purposes only. If you desire to reproduce or share content from third-party sources cited within this Center, you must first seek approval from that third-party source.